[Indications for high doses of corticosteroids in the combined therapy of acute leukemie. Biochemical, morphological and cytochemical basis (author's transl)].
D000293:Adolescent; D000328:Adult; D002648:Child; D004247:DNA / Q000096:biosynthesis; D004254:DNA Nucleotidyltransferases / Q000097:blood; D003857:Deoxyuridine / Q000097:blood; D004359:Drug Therapy, Combination; D005260:Female; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000201:enzymology; D008297:Male; D011239:Prednisolone / Q000008:administration & dosage*; D013936:Thymidine / Q000097:blood; D013937:Thymidine Kinase / Q000097:blood; D014316:Tritium; D014750:Vincristine / Q000008:administration & dosage
D014316:Tritium; D014750:Vincristine; D004247:DNA; D011239:Prednisolone; D013937:Thymidine Kinase; D004254:DNA Nucleotidyltransferases; D013936:Thymidine; D003857:Deoxyuridine
Indikation zur Anwendung hoher Corticosteroiddosen bei der Kombinationsbehandlung akuter Leukämien. Biochemische, morphologische und cytochemische Grundlagen.